Bicycle Therapeutics Plc
(NASDAQ) BCYC
Bicycle Therapeutics Plc Financials at a Glance
Market Cap
$239.66M
Revenue (TTM)
$63.50M
Net Income (TTM)
$219.03M
EPS (TTM)
$-3.17
P/E Ratio
-1.51
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$4.80
Volume
13,093
Open
$4.67
Price
$4.80
Volume
13,093
Open
$4.67
Previous Close
$4.80
Daily Range
$4.67 - $4.89
52-Week Range
$4.24 - $9.36
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$4.80
Volume
13,093
Open
$4.67
Previous Close
$4.80
Daily Range
$4.67 - $4.89
52-Week Range
$4.24 - $9.36
BCYC News
Is Bicycle Therapeutics Stock a Buy?
BCYC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bicycle Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
288
CEO
Kevin Lee, PhD, MBA
Website
www.bicycletherapeutics.comHeadquarters
Cambridge, CB22 3AT, GB
BCYC Financials
Key Financial Metrics (TTM)
Gross Margin
-12%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
-31%
Return on Capital
-40%
Return on Assets
-34%
Earnings Yield
-66.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$239.66M
Shares Outstanding
49.93M
Volume
13.09K
Avg. Volume
475.02K
Financials (TTM)
Gross Profit
$72.59M
Operating Income
$247.72M
EBITDA
$212.18M
Operating Cash Flow
$249.68M
Capital Expenditure
$2.36M
Free Cash Flow
$252.61M
Cash & ST Invst.
$628.11M
Total Debt
$17.52M
Bicycle Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$887.00K
-91.1%
Gross Profit
$887.00K
+101.9%
Gross Margin
100.00%
N/A
Market Cap
$239.66M
N/A
Market Cap/Employee
$785.78K
N/A
Employees
305
N/A
Net Income
$60.83M
-0.1%
EBITDA
$59.48M
+15.3%
Quarterly Fundamentals
Net Cash
$545.60M
-30.4%
Accounts Receivable
$40.92M
-11.8%
Inventory
$0.00
N/A
Long Term Debt
$13.87M
+307.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
-33.57%
N/A
Return on Invested Capital
-40.15%
N/A
Free Cash Flow
$66.64M
+23.7%
Operating Cash Flow
$65.92M
+24.0%